{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:40:15Z","timestamp":1791214815542,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Cancer Institute at the National Institutes of Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.bcp.2011.03.029","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T15:25:57Z","timestamp":1302881157000},"page":"110-121","source":"Crossref","is-referenced-by-count":54,"title":["Second generation benzofuranone ring substituted noscapine analogs: Synthesis and biological evaluation"],"prefix":"10.1016","volume":"82","author":[{"given":"Ram Chandra","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanthi","family":"Karna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushma Reddy","family":"Gundala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishali","family":"Pannu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Stanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Hope","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Lopus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maged","family":"Henary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Aneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2011.03.029_bib0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1317","article-title":"Microtubules as a target for anticancer drugs","volume":"4","author":"Jordan","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bcp.2011.03.029_bib0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1568011053352569","article-title":"Targeting microtubules for cancer chemotherapy","volume":"5","author":"Zhou","year":"2005","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"10.1016\/j.bcp.2011.03.029_bib0015","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1073\/pnas.95.4.1601","article-title":"Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells","volume":"95","author":"Ye","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2011.03.029_bib0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0165-6147(03)00161-5","article-title":"Microtubule-interacting drugs for cancer treatment","volume":"24","author":"Checchi","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bcp.2011.03.029_bib0025","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s002620000109","article-title":"Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses","volume":"49","author":"Ke","year":"2000","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.bcp.2011.03.029_bib0030","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1158\/0008-5472.CAN-09-4230","article-title":"Noscapine, a benzylisoquinoline alkaloid, sensitizes leukemic cells to chemotherapeutic agents and cytokines by modulating the NF-kappaB signaling pathway","volume":"70","author":"Sung","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.03.029_bib0035","first-page":"4109","article-title":"Noscapine alters microtubule dynamics in living cells and inhibits the progression of melanoma","volume":"62","author":"Landen","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.03.029_bib0040","doi-asserted-by":"crossref","first-page":"39777","DOI":"10.1074\/jbc.M203927200","article-title":"Paclitaxel-resistant human ovarian cancer cells undergo c-Jun NH2-terminal kinase-mediated apoptosis in response to noscapine","volume":"277","author":"Zhou","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2011.03.029_bib0045","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1158\/1078-0432.CCR-04-0360","article-title":"Noscapine crosses the blood-brain barrier and inhibits glioblastoma growth","volume":"10","author":"Landen","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2011.03.029_bib0050","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1158\/0008-5472.CAN-05-2962","article-title":"Rational design of the microtubule-targeting anti-breast cancer drug EM015","volume":"66","author":"Aneja","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.03.029_bib0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00280-008-0720-z","article-title":"Antitumor activity of noscapine in human non-small cell lung cancer xenograft model","volume":"63","author":"Jackson","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bcp.2011.03.029_bib0060","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1158\/0008-5472.CAN-06-4282","article-title":"p53 and p21 determine the sensitivity of noscapine-induced apoptosis in colon cancer cells","volume":"67","author":"Aneja","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.03.029_bib0065","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1124\/mol.105.021899","article-title":"Development of a novel nitro-derivative of noscapine for the potential treatment of drug-resistant ovarian cancer and T-cell lymphoma","volume":"69","author":"Aneja","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.03.029_bib0070","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1158\/1535-7163.MCT-06-0205","article-title":"Treatment of hormone-refractory breast cancer: apoptosis and regression of human tumors implanted in mice","volume":"5","author":"Aneja","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2011.03.029_bib0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1476-4598-8-93","article-title":"EM011 activates a survivin-dependent apoptotic program in human non-small cell lung cancer cells","volume":"8","author":"Karna","year":"2009","journal-title":"Mol Cancer"},{"key":"10.1016\/j.bcp.2011.03.029_bib0080","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.ejca.2010.02.017","article-title":"A novel microtubule-modulating agent induces mitochondrially driven caspase-dependent apoptosis via mitotic checkpoint activation in human prostate cancer cells","volume":"46","author":"Aneja","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bcp.2011.03.029_bib0085","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ijc.24765","article-title":"Non-toxic melanoma therapy by a novel tubulin-binding agent","volume":"126","author":"Aneja","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2011.03.029_bib0090","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00280-007-0430-y","article-title":"Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent","volume":"60","author":"Aneja","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bcp.2011.03.029_bib0095","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bcp.2006.05.004","article-title":"Synthesis of microtubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death","volume":"72","author":"Aneja","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2011.03.029_bib0100","doi-asserted-by":"crossref","first-page":"8352","DOI":"10.1016\/j.bmc.2006.09.012","article-title":"Synthesis and biological evaluation of a cyclic ether fluorinated noscapine analog","volume":"14","author":"Aneja","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bcp.2011.03.029_bib0105","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1124\/mol.63.4.799","article-title":"Brominated derivatives of noscapine are potent microtubule-interfering agents that perturb mitosis and inhibit cell proliferation","volume":"63","author":"Zhou","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.03.029_bib0110","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1182\/blood-2005-08-3516","article-title":"Drug-resistant T-lymphoid tumors undergo apoptosis selectively in response to an antimicrotubule agent, EM011","volume":"107","author":"Aneja","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2011.03.029_bib0115","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1158\/0008-5472.CAN-07-1874","article-title":"Multidrug resistance-associated protein-overexpressing teniposide-resistant human lymphomas undergo apoptosis by a tubulin-binding agent","volume":"68","author":"Aneja","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.03.029_bib0120","doi-asserted-by":"crossref","first-page":"2216a","DOI":"10.1182\/blood-2005-12-5142","article-title":"Microtubules leukemia, and cough syrup","volume":"107","author":"Heidemann","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2011.03.029_bib0125","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1021\/jm050674q","article-title":"Identification of novel and improved antimitotic agents derived from noscapine","volume":"48","author":"Anderson","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2011.03.029_bib0130","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1021\/jm0494220","article-title":"Discovery of S-phase arresting agents derived from noscapine","volume":"48","author":"Anderson","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2011.03.029_bib0135","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature02393","article-title":"Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain","volume":"428","author":"Ravelli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2011.03.029_bib0140","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","article-title":"PHASE a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results","volume":"20","author":"Dixon","year":"2006","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.bcp.2011.03.029_bib0145","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bcp.2011.03.029_bib0150","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2165\/00003088-199834020-00004","article-title":"Pharmacokinetics and pharmacodynamics of estramustine phosphate","volume":"34","author":"Bergenheim","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bcp.2011.03.029_bib0155","first-page":"3","article-title":"Preparation of microtubule protein and purified tubulin from bovine brain by cycles of assembly and disassembly and phosphocellulose chromatography","volume":"95","author":"Miller","year":"2010","journal-title":"Methods Cell Biol"},{"key":"10.1016\/j.bcp.2011.03.029_bib0160","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0022-2836(74)90048-5","article-title":"Turbidimetric studies of the in vitro assembly and disassembly of porcine neurotubules","volume":"89","author":"Gaskin","year":"1974","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bcp.2011.03.029_bib0165","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/cdd.2010.133","article-title":"A novel microtubule-modulating noscapinoid triggers apoptosis by inducing spindle multipolarity via centrosome amplification and declustering","volume":"18","author":"Karna","year":"2011","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.bcp.2011.03.029_bib0170","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1021\/jm050362n","article-title":"A critical assessment of docking programs and scoring functions","volume":"49","author":"Warren","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2011.03.029_bib0175","first-page":"29","article-title":"Application of organic carbamates in drug design. Part 1: anticancer agents\u2014recent reports","author":"Ray","year":"2004","journal-title":"Drugs of the Future"},{"key":"10.1016\/j.bcp.2011.03.029_bib0180","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1124\/mol.64.2.382","article-title":"Molecular modes of action of artesunate in tumor cell lines","volume":"64","author":"Efferth","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.03.029_bib0185","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.tpj.6500371","article-title":"Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins","volume":"6","author":"Anfosso","year":"2006","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.bcp.2011.03.029_bib0190","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1634\/theoncologist.3-6-373","article-title":"Paclitaxel in Breast Cancer","volume":"3","author":"Perez","year":"1998","journal-title":"Oncologist"},{"issue":"Suppl. 3","key":"10.1016\/j.bcp.2011.03.029_bib0195","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1038\/sj.bjc.6601495","article-title":"Docetaxel: an alternative taxane in ovarian cancer","volume":"89","author":"Katsumata","year":"2003","journal-title":"Br J Cancer"},{"issue":"Suppl. 2","key":"10.1016\/j.bcp.2011.03.029_bib0200","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1634\/theoncologist.9-suppl_2-24","article-title":"Docetaxel and paclitaxel in the treatment of breast cancer: a review of clinical experience","volume":"9","author":"Crown","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.bcp.2011.03.029_bib0205","first-page":"1390","article-title":"The Vinca alkaloids: a new class of oncolytic agents","volume":"23","author":"Johnson","year":"1963","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.03.029_bib0210","first-page":"O1","article-title":"The role of beta-tubulin isotypes in resistance to antimitotic drugs","volume":"1471","author":"Burkhart","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2011.03.029_bib0215","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1128\/MCB.2.6.720","article-title":"Revertants of a Chinese hamster ovary cell mutant with an altered beta-tubulin: evidence that the altered tubulin confers both colcemid resistance and temperature sensitivity on the cell","volume":"2","author":"Cabral","year":"1982","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2011.03.029_bib0220","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/jsre.2001.6126","article-title":"Mechanisms of taxotere-related drug resistance in pancreatic carcinoma","volume":"99","author":"Liu","year":"2001","journal-title":"J Surg Res"},{"key":"10.1016\/j.bcp.2011.03.029_bib0225","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0074-7696(08)62372-4","article-title":"Tubulin isotypes and the multigene tubulin families","volume":"85","author":"Cowan","year":"1983","journal-title":"Int Rev Cytol"},{"key":"10.1016\/j.bcp.2011.03.029_bib0230","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1172\/JCI119642","article-title":"Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes","volume":"100","author":"Kavallaris","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2011.03.029_bib0235","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/117693510700300028","article-title":"The roles of beta-tubulin mutations and isotype expression in acquired drug resistance","volume":"3","author":"Huzil","year":"2007","journal-title":"Cancer Inform"},{"key":"10.1016\/j.bcp.2011.03.029_bib0240","first-page":"5803","article-title":"Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells","volume":"61","author":"Kavallaris","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.03.029_bib0245","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2741\/3728","article-title":"Investigations of survivin: the past, present and future","volume":"16","author":"Cheung","year":"2011","journal-title":"Front Biosci"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295211002164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295211002164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T05:14:24Z","timestamp":1592457264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295211002164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0006295211002164"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2011.03.029","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}